Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Blake Beber

Advertisement

Articles by Blake Beber

New Standards for First-to-Launch Players

ByEduardo Schur,Blake Beber,Maya Desai,Justin Zamirowski
September 14th 2020

While COVID-19 has shifted some of the rules, research reveals that practice changes were already afoot for market newcomers.

figure 1.png

Research Reveals New Launch Standards for First-to-Launch Pharma and Biotech Companies in the U.S.

ByMaya Desai,Blake Beber,Justin Zamirowski,Eduardo Schur
June 26th 2020

While COVID-19 has shifted the rules of the healthcare industry, research shows there was already progress on changes being made for how pharma companies are launching products.

Advertisement

Latest Updated Articles

  • New Standards for First-to-Launch Players
    New Standards for First-to-Launch Players

    September 14th 2020

  • figure 1.png
    Research Reveals New Launch Standards for First-to-Launch Pharma and Biotech Companies in the U.S.

    June 26th 2020



Advertisement
Advertisement

Trending on PharmExec

1

Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts

2

The Bottlenecks That Slow Manufacturer Response to Increased Demand for Production

3

Roundup: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy, Enodia Therapeutics Enters Collaboration and License Agreement to Develop Sec61-Targeting Small Molecules

4

The Manufacturing Issues That Continue to Contribute to Drug Shortages

5

Pharmaceutical Executive Daily: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy with Roche

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us